Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: The Atherosclerosis Risk in Communities (ARIC) Study

Atherosclerosis

Volumn 216, Issue 1, 2011, Pages 151-156

  Kucharska Newton, Anna M ^a   Monda, Keri L ^a   Campbell, Stephen ^a   Bradshaw, Patrick T ^a   Wagenknecht, Lynne E ^b   Boerwinkle, Eric ^c   Wasserman, Bruce A ^d   Heiss, Gerardo ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Coronary heart disease; Magnetic resonance imaging (MRI); Plaque; Platelets

Indexed keywords

FIBRINOGEN RECEPTOR; LEUCINE; PROLINE;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; FEMALE; HUMAN; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INTEGRIN BETA3; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; P-SELECTIN; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RISK ASSESSMENT; RISK FACTORS; RUPTURE, SPONTANEOUS; UNITED STATES;

EID: 79955540744     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.038     Document Type: Article

References (30)

1. Aikawa M., Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004, 13:125-138.
2. Kolodgie F.D., Burke A.P., Farb A., et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol 2001, 16:285-292.
3. Bennett J.S. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest 2005, 115:3363-3369.
4. Andrieux A., Hudry-Clergeon G., Ryckewaert J.J., et al. Amino acid sequences in fibrinogen mediating its interaction with its platelet receptor, GPIIbIIIa. J Biol Chem 1989, 264:9258-9265.
5. Farrell D.H., Thiagarajan P., Chung D.W., Davie E.W. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 1992, 89:10729-10732.
6. Schmugge M., Rand M.L., Freedman J. Platelets and von Willebrand factor. Transfus Apher Sci 2003, 28:269-277.
7. Furie B., Furie B.C. Mechanisms of thrombus formation. N Engl J Med 2008, 359:938-949.
8. Ruggeri Z.M., Mendolicchio G.L. Adhesion mechanisms in platelet function. Circ Res 2007, 100:1673-1685.
9. Rivera J., Lozano M.L., Navarro-Nunez L., Vicente V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009, 94:700-711.
10. Main A.L., Harvey T.S., Baron M., Boyd J., Campbell I.D. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell 1992, 71:671-678.
11. Di Castelnuovo A., de Gaetano G., Donati M.B., Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis. Thromb Haemost 2001, 85:626-633.
12. Zhu M.M., Weedon J., Clark L.T. Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000, 86(A8):1000-5.
13. The Aric I. The Atherosclerosis Risk IN Communities (ARIC) Study:Design and Objectives. Am J Epidemiol 1989, 129:687-702.
14. Wagenknecht L., Wasserman B., Chambless L., et al. Correlates of carotid plaque presence and composition as measured by MRI: the Atherosclerosis Risk in Communities Study. Circ Cardiovasc Imaging 2009, 2:314-322.
15. Wasserman BA, Astor BC, Sharrett AR, Swingen C, Catellier D. MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 31:406-15.
16. Catellier D.J., Aleksic N., Folsom A.R., Boerwinkle E. Atherosclerosis Risk in Communities (ARIC) Carotid MRI flow cytometry study of monocyte and platelet markers: intraindividual variability and reliability. Clin Chem 2008, 54:1363-1371.
17. Jolliffe I.T. Principal components analysis 2002, Springer-Verlag.
18. Weiss E.J., Bray P.F., Tayback M., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996, 334:1090-1094.
19. Savage B., Saldivar E., Ruggeri Z.M. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996, 84:289-297.
20. Coller B.S. Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics. J Clin Invest 1997, 99:1467-1471.
21. Zeymer U., Wienbergen H. A review of clinical trials with eptifibatide in cardiology. Cardiovasc Drug Rev 2007, 25:301-315.
22. Marian A.J., Brugada R., Kleiman N.S., et al. Platelet glycoprotein IIIa PlA polymorphism and myocardial infarction. N Engl J Med 1996, 335:1071-1074.
23. Mikkelsson J., Perola M., Laippala P., et al. Glycoprotein IIIa PlA polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. Arterioscler Thromb Vasc Biol 1999, 19:2573-2578.
24. Mikkelsson J., Perola M., Laippala P., Penttila A., Karhunen P.J. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death. J Am Coll Cardiol 2000, 36:1317-1323.
25. Meiklejohn D.J., Urbaniak S.J., Greaves M. Platelet glycoprotein IIIa polymorphism HPA 1b (PlA2): no association with platelet fibrinogen binding. Br J Haematol 1999, 105:664-666.
26. Goodall A.H., Curzen N., Panesar M., et al. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2 Zwb) positive platelets in patients with cardiovascular disease. Eur Heart J 1999, 20:742-747.
27. Michelson A.D., Furman M.I., Goldschmidt-Clermont P., et al. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists. Circulation 2000, 101:1013-1018.
28. Kim H.O., Jin Y., Kickler T.S., et al. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995, 35:863-867.
29. Lim J., Lal S., Ng K.C., et al. Variation of the platelet glycoprotein IIIa PIA1/A2 allele frequencies in the three ethnic groups of Singapore. Int J Cardiol 2003, 90:269-273.
30. Kekomaki S., Partanen J., Kekomaki R. Platelet alloantigens HPA-1, -2, -3 -5 and -6b in Finns. Transfus Med 1995, 5:193-198.